Colorimetric study helps identify promising therapeutics for prostate cancer
Researchers at the University of Bath (UK) have developed a test to allow structure-activity relationship studies to be carried out on a key prostate cancer protein, revealing potential inhibitor compounds.
Please sign in or register for FREE
Sign in to MedChemNet
Register to MedChemNet
MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.